FDA
-
-
-
-
-
-
-
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
-
-
-
-
-
-
-
Eton Pharmaceuticals relaunches HEMANGEOL through specialty pharmacy
-
-
-
-
-
-
-
Eton Pharmaceuticals receives FDA approval for DESMODA oral solution
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
-
-
-
-
-
-
-
Eton Pharmaceuticals Inc. (ETON) Announces Positive Pivotal Clinical Study Results for ET-600
-
-
-
-
-
-
-
Eton Pharmaceuticals (ETON) PT Lowered to $33 at H.C. Wainwright
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKEĀ® Clinical Trial
-
334,166 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


